Market Access/ News/ News Poolbeg licences candidate for broad-spectrum respiratory infections Joy Persaud coronavirus, infectious disease, influenza, pharma, Poolbeg Pharma, viruses 0 Comment Poolbeg Pharma has licenced a candidate for nasal immunotherapy, developed by the University of Warwick, targeting respiratory infections, Share X Poolbeg licences candidate for broad-spectrum respiratory infections https://pharmaphorum.com/news/poolbeg-licences-candidate-for-broad-spectrum-respiratory-infections/